The bottom line question is : can the use of statins reduce mortality in HIV patients on HAART? It was proposed that the pleomorphic effects of this drug class could act reverting the state of chronic dysregulated inflammation seen in HIV infection. In case of beneficial effects, does this effect exist regardless of cholesterol levels, like the data of JUPITER trial?